Investigation of the molecular difference of plasma lipids in mice with idiopathic pulmonary fibrosis based on lipidomics

Acta Universitatis Medicinalis Anhui 2025 04 v.60 642-648     font:big middle small

Found programs: National Natural Science Foundation of China (No.U21A20334);Natural Science Foundation of Hebei Province (Nos.H2022209021,H2022209039);College Student Innovation and Entrepreneurship Training Project (No.202410081004)

Authors:Wu Qingshuang; Qi Rong; Zheng Chunchao; Sun Yanan; Liu Heliang; Wang Hongli; He Hailan

Keywords:idiopathic pulmonary fibrosis;plasma;lipidomics;phosphatidylcholine;lysophosphatidylcholine

DOI:10.19405/j.cnki.issn1000-1492.2025.04.008

〔Abstract〕 Objective To explore the differential lipid metabolites in the plasma of mice with idiopathic pulmonary fibrosis(IPF). Methods Thirty SPF C57BL/6 male mice were randomly divided into 2 groups with 15 mice in each group. The experimental groups were divided into control group and bleomycin(BLM) group. The model of idiopathic pulmonary fibrosis was induced by one-time intratracheal infusion of BLM(1 mg/kg). Hematoxylin-eosin(HE) staining was used to observe the lung histopathology. The collagen fiber deposition in lung tissue was observed by Sirius red staining. The differential lipid metabolites in plasma of IPF mice were screened and enriched by lipidomics. Results HE staining showed that the pulmonary tissue structure was disordered, alveolar septum was broken and alveolar wall was destroyed in BLM group. Sirius red staining showed a large amount of collagen fiber deposition in the lung interstitium of BLM group. The results of lipidomics analysis showed that the lipid metabolism profile of BLM group changed, 15 differential lipid metabolites were screened out, of which 11 differential lipid metabolites were up-regulated, and 4 differential lipid metabolites were down-regulated, mainly concentrated in glycerophosphoglycerophosphates, glycerophosphocholines, steroid lactones, etc. Conclusion The lipid metabolism profile of BLM group mice changes, differential lipid metabolites such as phosphoglycolate phosphatase(PGP)(18:0/18:0), PGP(i-12:0/i-24:0), PGP(i-13:0/a-25:0), and phosphatidylcholine(PC)(18:0/14:0), PC(18:3/16:0), lysophosphatidylcholine(LPC)(16:1), and LPC(18:3) may play an important role in the progression of IPF. These findings provide a new reference for further study of the molecular mechanism of IPF, and also provide a potential new target for clinical treatment.